Expect Pregnancy Letter Categories to be Phased Out

August 2015

You'll see LESS use of pregnancy categories (A, B, C, D, X).

In fact, Briggs' Drugs in Pregnancy and Lactation no longer references these U.S. Food and Drug Administration (FDA) risk categories.

Plus pregnancy letter categories are gradually disappearing from U.S. drug labelling and will be removed completely by 2020.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Antithrombotics Suggest "Bridging" Fewer Warfarin Patients With Enoxaparin
COPD Explain Where Inspiolto Respimat and Duaklir Genuair Fit In for COPD
Insulin Explain That a "Unit Is a Unit" With Insulin Products
Insulin Don't Think of Toujeo as an Option When High Insulin Doses Are Needed
Kidney Stones Don't Routinely Recommend Tamsulosin or Nifedipine to Pass Kidney Stones
Asthma Help Select an Appropriate Spacer for Preschoolers With Asthma
Osteoarthritis Don't Remove Acetaminophen From Your Osteoarthritis Toolbox
Photosensitivity Advise Taking Photosensitizing Meds in the Evening if Appropriate
Prediabetes Help Identify Patients at Risk for Prediabetes
Opioids Expect Long-Term Buprenorphine/Naloxone Therapy for Opioid Dependence
Pregnancy Expect Pregnancy Letter Categories to be Phased Out
Practice We're growing and hiring
Recognize When You're Receiving a Teletypewriter Call